Symbiotec Pharmalab’s IPO saw strong investor demand, closing oversubscribed 71.26 times. The company aimed to raise Rs 1,757 crore through a fresh issue and offer for sale. Anchor investors contributed Rs 526.20 crore before the public issue opened.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.